Quidel | QDEL - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Agilent USD 25M 2M 2025-12
Avanos Medical USD 1.9M 100K 2025-12
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bruker USD 20M 4.3M 2025-09
Cerus USD 2.33M 96K 2024-06
Charles River Laboratories USD 23.78M 1.63M 2025-12
Danaher USD 63M 8M 2026-03
Haemonetics USD 7.21M 3.14M 2025-09
Illumina USD 25M 0 2025-09
IQVIA Holdings USD 193M 4M 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
Neogen USD 13.9M 356K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quidel USD 5.68B 5.63B 2025-09
Revvity USD 23.51M 742K 2025-12
STAAR Surgical USD 800K 799K 2025-09
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 8.62M 18.02M 2025-12